Click here TO BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
| |
 |
December 2021 e-book |
|
| |
 |
Magazine e-book |
This issue of World Pharma Today presents the fact that how future ready are our pharmaceutical companies when it comes to taking care of the existing standards and what are they currently up to considering the phenomenal changes that are taking place in health gamut.
Grab your copy now!
|
|
|
|
| |
 |
Featured Articles |
|
| |
|
|
Antibiotic powders : Maximum safety and efficiency during filling
Pharmaceutical powders form the basis for numerous antibiotics that are essential for comprehensive medical care. However, margins are low and production conditions are complex.
|
|
| |
Accelerating Asia's digital GMP transformation with industry 4.0 technologies
The Asia-Pacific region's dominance in the global manufacturing sector has never been stronger. According to a recent Financial Times Supply Chain..
|
|
|
|
| |
|
|
How innovation and responsibility contribute to patient's well-being
In the health care industry, changes are occurring at a rapid pace. People, machines, and information are becoming even more interconnected. Meanwhile, unanticipated events such as the Covid-19...
|
|
| |
What is the Internet of Behaviours and why Pharma and Health Brands should be paying attention
The IoT has been the topic of discussion for many years in the technology and data circles. However, the Internet cannot exist without people and what they...
|
|
|
|
| |
|
|
Viral Vector Vaccine Manufacture: A Glance at the Future on our Doorstep
Today, within the pandemic situation, mRNA or gene therapy is no longer unknown to us. Whether you are a gardener, computer engineer, or dentist, we have all received an accelerated course on how biologics...
|
|
| |
Tackling challenges in the pharmaceutical industry through digitalization
Patient safety and ensuring compliance with regulations including FDA Current Good Manufacturing Practice and 21 CFR part 11 - are the top priorities in the pharmaceutical industry.
|
|
|
|
| |
|
|
A key decision in sterile manufacturing: Choosing the right CDMO partner
Contamination of drug substances and drug products leads to a risk of harm. This risk is particularly high in drugs delivered via the intravenous or ophthalmic routes, as these drugs bypass many of the body...
|
|
|
